| Dr Colin T Graney, DPM | |
|
664 W. Washington Ave, Madison, WI 53703 | |
| (608) 241-0848 | |
| (941) 845-4963 |
| Full Name | Dr Colin T Graney |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 9 Years |
| Location | 664 W. Washington Ave, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295279461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO3957 (Florida) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1152-25 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upland Hills Health | Dodgeville, WI | Hospital |
| Stoughton Hospital | Stoughton, WI | Hospital |
| Meriter Hospital | Madison, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Madison Advanced Foot And Ankle Llc | 8123353810 | 2 |
| Upland Hills Health Inc | 3072415553 | 51 |
News Archive
Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National Institutes of Health scientists and colleagues.
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
The value of routine body mass index (BMI) screening in schools has been a topic of ongoing controversy. An expert Roundtable Discussion in the current issue of Childhood Obesity, a peer-reviewed journal published by Mary Ann Liebert, Inc., debates the pros and cons of routine BMI screening in the school setting, discusses the most recent data, and explores when and for what purpose BMI screening results should be shared with parents and the potential benefits.
S*BIO Pte Ltd today announced the initiation of a Phase 2 clinical trial of SB939, its novel orally-active HDAC inhibitor, in patients with recurrent or metastatic prostate cancer (HRPC).
Parents of teenagers frustrated by their children's inability to focus on more than one thing at a time can take hope: a new study from researchers at the University of Minnesota in Minneapolis finds behavioral evidence that the part of the brain responsible for the ability to multi-task continues to develop until late adolescence.
› Verified 4 days ago
| Provider Name | Upland Hills Health Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821258740 PECOS PAC ID: 3072415553 Enrollment ID: O20081016000442 |
News Archive
Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National Institutes of Health scientists and colleagues.
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
The value of routine body mass index (BMI) screening in schools has been a topic of ongoing controversy. An expert Roundtable Discussion in the current issue of Childhood Obesity, a peer-reviewed journal published by Mary Ann Liebert, Inc., debates the pros and cons of routine BMI screening in the school setting, discusses the most recent data, and explores when and for what purpose BMI screening results should be shared with parents and the potential benefits.
S*BIO Pte Ltd today announced the initiation of a Phase 2 clinical trial of SB939, its novel orally-active HDAC inhibitor, in patients with recurrent or metastatic prostate cancer (HRPC).
Parents of teenagers frustrated by their children's inability to focus on more than one thing at a time can take hope: a new study from researchers at the University of Minnesota in Minneapolis finds behavioral evidence that the part of the brain responsible for the ability to multi-task continues to develop until late adolescence.
› Verified 4 days ago
| Provider Name | Madison Advanced Foot & Ankle Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487216255 PECOS PAC ID: 8123353810 Enrollment ID: O20190717003361 |
News Archive
Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National Institutes of Health scientists and colleagues.
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
The value of routine body mass index (BMI) screening in schools has been a topic of ongoing controversy. An expert Roundtable Discussion in the current issue of Childhood Obesity, a peer-reviewed journal published by Mary Ann Liebert, Inc., debates the pros and cons of routine BMI screening in the school setting, discusses the most recent data, and explores when and for what purpose BMI screening results should be shared with parents and the potential benefits.
S*BIO Pte Ltd today announced the initiation of a Phase 2 clinical trial of SB939, its novel orally-active HDAC inhibitor, in patients with recurrent or metastatic prostate cancer (HRPC).
Parents of teenagers frustrated by their children's inability to focus on more than one thing at a time can take hope: a new study from researchers at the University of Minnesota in Minneapolis finds behavioral evidence that the part of the brain responsible for the ability to multi-task continues to develop until late adolescence.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Colin T Graney, DPM 664 W. Washington Ave, Madison, WI 53703 Ph: (608) 241-0848 | Dr Colin T Graney, DPM 664 W. Washington Ave, Madison, WI 53703 Ph: (608) 241-0848 |
News Archive
Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National Institutes of Health scientists and colleagues.
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
The value of routine body mass index (BMI) screening in schools has been a topic of ongoing controversy. An expert Roundtable Discussion in the current issue of Childhood Obesity, a peer-reviewed journal published by Mary Ann Liebert, Inc., debates the pros and cons of routine BMI screening in the school setting, discusses the most recent data, and explores when and for what purpose BMI screening results should be shared with parents and the potential benefits.
S*BIO Pte Ltd today announced the initiation of a Phase 2 clinical trial of SB939, its novel orally-active HDAC inhibitor, in patients with recurrent or metastatic prostate cancer (HRPC).
Parents of teenagers frustrated by their children's inability to focus on more than one thing at a time can take hope: a new study from researchers at the University of Minnesota in Minneapolis finds behavioral evidence that the part of the brain responsible for the ability to multi-task continues to develop until late adolescence.
› Verified 4 days ago
Ruben Silva, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2500 Overlook Ter, Madison, WI 53705 Phone: 888-478-8321 | |
Steven J. Merckx, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6661 Odana Road, Madison, WI 53719 Phone: 608-829-2535 Fax: 608-829-1319 | |
Associated Podiatrists, Llp Podiatrist Medicare: Medicare Enrolled Practice Location: 6661 Odana Rd, Madison, WI 53719 Phone: 608-829-2535 Fax: 608-829-1319 | |
Neal Jay Katz, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 664 W Washington Ave, Madison, WI 53703 Phone: 608-241-0848 Fax: 608-767-2015 | |
Nealan Marshall Prather, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2500 Overlook Ter, Madison, WI 53705 Phone: 608-256-1901 | |
Stephen C Bogue, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6661 Odana Road, Madison, WI 53719 Phone: 608-829-2535 Fax: 608-829-1319 | |
Dr. Robyn Winner Paloian, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 451 Junction Rd, Madison, WI 53717 Phone: 608-263-8915 Fax: 608-265-5755 |